As a major conference on tuberculosis nears, Doctors Without Borders is pressuring suppliers of key medicines — Johnson & Johnson (JNJ), Mylan (MYL) and Otsuka Pharmaceuticals — to lower their prices by significant amounts.

As part of its effort, the nonprofit is protesting outside J&J offices in several countries to demand the health care giant slash the price of Sirturo by half — to $1 a day. Currently, the lowest price J&J charges for a 20-month treatment course is $1,200, or $2 a day, in countries eligible to buy the drug through the Global Drug Facility, a purchasing mechanism run by Stop TB Partnership, a United Nations program.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy